Sutton Wealth Advisors Inc. Acadia Pharmaceuticals Inc Transaction History

Sutton Wealth Advisors Inc.

  • $203 Billion
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Nov 06, 2023
SELL
$15.07 - $22.34 $5,621 - $8,332
-373 Closed
0 $0
Q4 2017

Nov 06, 2023
SELL
$26.84 - $39.14 $12,212 - $17,808
-455 Reduced 54.95%
373 $11.2 Million
Q4 2016

Nov 06, 2023
BUY
N/A
828 New
828 $23.9 Million
Q3 2016

Nov 06, 2023
SELL
N/A
-221 Closed
0 $0
Q2 2016

Nov 06, 2023
BUY
N/A
221
221 $7.17 Million

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.68B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email